MindMed Stock Price Targets [How HIGH can $MMED / $MMEDF Go?]🚀

Today we are going to discuss my 5 year price targets for MindMed, MMEDF on the American OTC market, MMED on the Canadian Neo market and MMQ on the European Frankfurt Stock exchange. Piggy backing off of a decades worth of positive research showing that substances like LSD, Ibogaine, psilocybin and MDMA can treat mental health illnesses better than current methods by an order of magnitude, MindMed is in my opinion by far the most advanced psychedelic medicines company that retail investors can buy on the public markets which is why MindMedicine is one of my top psychedelic stocks in 2021. In this video, we're going to look at 4 different 5 year price targets for MindMed, and assign them a level of probability. The four cases will be: 1. The 5 year bear case for MindMed's stock 2. The Neutral case for MindMed LT 3. The bull case price target for MindMed 4. The Super Bull case Timestamps: 0:00​ - Intro 2:54 - The Bear Case for MindMed 5:37 - The Neutral Case/ MindMed's Stagnation 7:49 - The Bull Case for MMED/MMEDF Stock 10:18 - The Super Bull Case for MindMed 13:08 - Note of Caution Plus Answer to Meor's Nasdaq question Just as a brief note, in this video we are going to be using MMEDF, and all figures will be in American dollars And because this is all going to be speculation, the entirety of the episode will take place in, The Speculation Zone I hope you guys found some value in this and I'll keep you posted for more changes! Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news! Follow us on social media! 🙌 Instagram: @psychedelicinvestor Email: thepsychedelicinvestor@gmail.com Facebook: @thepsychedelicinvestor Music: www.bensound.com https://benzinga.grsm.io/jameshallifax1834 https://benzinga.grsm.io/thepsychedelicinvestor DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments. #MindMed​​​ ​#MindmedStock​​​ #MMEDNews
How The Conscious Fund Is Changing Perceptions About Psychedelics

How The Conscious Fund Is Changing Perceptions About Psychedelics

UK venture capital fund The Conscious Fund is working to make psychedelics more accessible and functional in various capacities.

Could This DMT Company Break Through the Addiction Market? [ENTHEON:The Next Big Psychedelic Stock?]

Hey guys! Today's episode of "Could This DMT Company Break Through the Addiction Market?" is a little bit different. We'll cover a DMT company called Entheon BioMedical Corp, ticker symbol ENBI on the CSE and ENTBF on the OTC market. Entheon is a company trying to solve addiction through the use of DMT which is why I've had my eye on for a while now. Anyone who has learned anything about DMT knows how interesting this compound is and how much healing potential it may have. DMT is especially interesting to me because of the fact that it is naturally produced in our bodies and because of the anecdotal evidence surrounding its mystical capabilities. I've mentioned that an other videos but I'll say it again. It was actually through learning about DMT on the Joe Rogan Podcast that launched my interest into the healing potential of psychedelics in general. Specifically, his podcasts with Dennis McKenna were an eye opener that I can genuinely say changed my life, because it led to the creation of this channel. And one of the reasons I agreed to do this sponsored content was because when doing my research into Entheon, I learned that none other than Dennis McKenna was on the Scientific advisory board of the company, which gave me a boost in confidence. So in this video we are going to do four things: First give you a brief rundown on who Entheon is, the investment thesis, and the people behind the company. Second we are going to take you into the realm of DMT, where we will discuss what DMT even is, people’s experiences on the drug, and the scientific literature that is making the potential for using DMT for healing so exciting. Third, we will discuss Entheon’s upcoming Clinical trials testing the effectiveness of using DMT to treat addiction. MindMed (MMED) is also doing clinical trials with DMT so I'm excited to see the results. What do you guys think? Is DMT a better alternative than ibogaine to treat addiction? I hope you guys found some value in this and I'll keep you posted for more changes! Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news! Follow us on social media! 🙌 Instagram: @psychedelicinvestor Facebook: @thepsychedelicinvestor email: thepsychedelicinvestor@gmail.com Music: www.bensound.com DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments. All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change. The Psychedelic Investor was compensated $1,000 by Future Money Trends for the making of this video on Entheon Biomedical. James (The Psychedelic Investor) does not own a position in Entheon Biomedical and will not open one for at least 30 days after publication of this video. https://entheonbiomedical.com/ CSE: ENBI | OTCQB: ENTBF This video was conducted on behalf of Entheon Biomedical, and was funded by Gold Standard Media LLC. For our full disclaimer, please visit: https://www.goldstandardir.com/entheon-biomedical-disclaimer-85/ #MindMed​​​ ​#Entheon​​​ #PsychedelicStocks

This Week in Psychedelic Stocks [UPDATES ON MINDMED (MMED/MMEDF) CMPS, NUMI & ATAI, CYBIN]

In today's episode of "This Week in Psychedelic Stocks", we'll see some news on MindMed (MMED / MMEDF/MMQ), Compass Pathways (CMPS), Atai Life Sciences, Numinus Wellness (NUMI), Cybin. We will cover the latest developments in the field writ large. This means we will cover any stories that affect the all the companies in this field, as well as company specific developments. Timestamps: 0:00 - Intro 0:32 - Norway Decriminalization Bill 1:59 - Psychedelic Market Stats 3:21 - Magic Mushrooms to Treat Obesity 5:40 - Ketamine to Treat Suicidal Thoughts? 7:09 -The Acid King? 8:58 - MindMed (MMED/MMEDF/MMQ) Updates 10:04 - Compass Pathways (CMPS) Updates 11:44 - Atai Life Sciences Updates 14:02 - Numinus (NUMI) Updates 15:13 - CYBIN Updates So this is it for This Week in Psychedelic Stocks fellow psychedelic investors! I hope you guys found some value in this and I'll keep you posted for more changes! Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news! Follow us on social media! 🙌 Instagram: @psychedelicinvestor Facebook: @thepsychedelicinvestor Music: www.bensound.com DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments. #MindMed​​ ​#MindmedStock​​ #PsychedelicStocks
Psychedelic Business News Spotlight: March 12, 2021

Psychedelic Business News Spotlight: March 12, 2021

This week in psychedelic business news, Canada expands legal distribution for psychedelics, therapeutic DMT stroke treatment, and more.
Canada Expands Psychedelic Approvals for Numinus

Canada Expands Psychedelic Approvals for Numinus

Numinus Biosciences has received expanded regulatory approval in Canada for psychedelic use and distribution.

Compass Pathways Q4 Earnings Call Highlights [Is CMPS Closing In On MindMed?]

Hey guys! I promised ya'll that I will keep you updated on Compass Pathways (NASDAQ: CMPS) earnings call. There has been some pretty interesting developments on the company that I thought I should Bring to your attention. Compass Pathways is one of the psychedelic companies that is the furthest advanced in their clinical trials (Phase IIB to treat TRD). However, I wasn't aware that they are doing a LOT more. This is quite interesting because in my opinion, CMPS is not a one trick pony anymore and it might as well be in direct competition with my favorite company in this sector (MindMed). In this video, we'll cover: 1. Compass Pathways' Financials 2. Their IP 3. Therapists Training 4. Future Projects 5. Digital Technology I hope that this is not going to enrage the MindMed fan boys out there. I just thought that it might be interesting for some of you psychedelic investors. Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news! Follow us on social media! Instagram: @psychedelicinvestor Facebook: @thepsychedelicinvestor Music: www.bensound.com https://mindmed.co/wp-content/uploads/2020/11/investor-deck.pdf https://www.businesswire.com/news/home/20190905005528/en/Usona-Institute-Clinical-Trial-Psilocybin-Major-Depressive DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments. #CompassPathways #CMPS #MindMed
North America Is Poised to Take the Lead In Emerging Psychedelic Drug Market

North America Is Poised to Take the Lead In Emerging Psychedelic Drugs Market

,
The psychedelic drugs market is finding a strong base in North America, according to new data. The U.S. and Canada in particular are supporting its expansion.
New App Creates Psychedelic Experience Without the Need for Substances

Can An App Give You a Psychedelic Experience Without Taking Drugs? Lumenate Says Yes

,
Lumenate is an app that simulates a psychedelic experience without the need for illegal substances.

MindMed Raises $19.5 Million // What Does This Mean for MMEDF/MMED? [Plus Upcoming Market CRASH?]

Hey guys! Today's episode is more of a fast rant on the recent press release about MindMed raising ANOTHER $19.5M from Canaccord Genuity Corp, on a deal that is set to close tomorrow, March 9th. Here, I'm discussing: 1. The number MindMed shares being sold and their respective price; 2.Why is MindMed doing this? 3. Potential short term and long term effects on MMED's stock price 4. Nasdaq uplisting? 5. Market crash thoughts I hope you guys found some value in this and I'll keep you posted for more changes! Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news! Follow us on social media! 🙌 Instagram: @psychedelicinvestor Facebook: @thepsychedelicinvestor Music: www.bensound.com DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments. #MindMed​​ ​#MindmedStock​​ #MMEDNews